Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 11, Issue 2, Pages 87-93
http://dx.doi.org/10.1080/09629350220131935

Serum levels of TNF-α, sIL-2R, IL-6, and IL-8 are increased and associated with elevated lipid peroxidation in patients with Behçet's disease

1Department of Ophthalmology, Gaziantep University Medical Faculty, Research Hospital, Gaziantep, Turkey
2Department of Biochemistry, Inönü University Medical Faculty, Turgut Ozal Medical Centre, Research Hospital, Malatya, Turkey
3Sivas Cad. Cebeci Apt. A-Blok, 175/15, Kayseri TR-38020, Turkey

Copyright © 2002 Hindawi Publishing Corporation. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [150 citations]

The following is the list of published articles that have cited the current article.

  • C. Evereklioglu, H.S. Inaloz, N. Kirtak, S. Doganay, M. Bulbul, B. Otlu, E. Ozerol, H. Er, and E. Ozbek, “Serum leptin concentration is increased in patients with Behcet's syndrome and is correlated with disease activity,” British Journal of Dermatology, vol. 147, no. 2, pp. 331–336, 2002. View at Publisher · View at Google Scholar
  • E. H. Hughes, and A. D. Dick, “The pathology and pathogenesis of retinal vasculitis,” Neuropathology and Applied Neurobiology, vol. 29, no. 4, pp. 325–340, 2003. View at Publisher · View at Google Scholar
  • C Evereklioglu, M Cekmen, A Ozkiris, L Karabas, and M Calis, “The pathophysiological significance of red blood cell nitric oxide concentrations in inflammatory Behcet's disease,” Mediators Of Inflammation, vol. 12, no. 4, pp. 255–256, 2003. View at Publisher · View at Google Scholar
  • Kuddusi Erkiliç, Cem Evereklioglu, Mustafa Çekmen, Abdullah Özkiris, Fuat Duygulu, and Hakki Dogan, “Adenosine deaminase enzyme activity is increased and negatively correlates with catalase, superoxide dismutase and glutathione peroxidase in patients with Behçet's disease: Original contributions/clinical and laboratory investigations,” Mediators of Inflammation, vol. 12, no. 2, pp. 107–116, 2003. View at Publisher · View at Google Scholar
  • Diomira Luongo, Paolo Bergamo, and Mauro Rossi, “Effects of conjugated linoleic acid on growth and cytokine expression in Jurkat T cells,” Immunology Letters, vol. 90, no. 2-3, pp. 195–201, 2003. View at Publisher · View at Google Scholar
  • Midori Misumi, Eri Hagiwara, Mitsuhiro Takeno, Yukiko Takeda, Yuko Inoue, Takashi Tsuji, Atsuhisa Ueda, Satoshi Nakamura, Shigeaki Ohno, and Yoshiaki Ishigatsubo, “Cytokine production profile in patients with Behcet's disease treated with infliximab,” Cytokine, vol. 24, no. 5, pp. 210–218, 2003. View at Publisher · View at Google Scholar
  • Nursen Düzgün, Ergin Ayaslioglu, Hüseyin Tutkak, and Olcay T. Aydintug, “Cytokine inhibitors: soluble tumor necrosis factor receptor 1 and interleukin-1 receptor antagonist in Behçet’s disease,” Rheumatology International, vol. 25, no. 1, pp. 1–5, 2003. View at Publisher · View at Google Scholar
  • M. Çekmen, C. Evereklioglu, H. Er, H. S. Inalöz, S. Doganay, and I. H. Özerol, “Vascular endothelial growth factor levels are increased and associated with disease activity in patients with Behçet's syndrome,” International Journal of Dermatology, vol. 42, no. 11, pp. 870–875, 2003. View at Publisher · View at Google Scholar
  • Cem Evereklioglu, Emin Ozbek, Mustafa Cekmen, Nihayet Mehmet, Fuat Duygulu, Abdullah Ozkiris, Mustafa Calip, Hamdi Er, and Yusuf Turkoz, “Urinary nitric oxide levels are increased and correlated with plasma concentrations in patients with Behcet's disease: Is it a new urinary activity marker?,” Nephrology, vol. 8, no. 5, pp. 231–238, 2003. View at Publisher · View at Google Scholar
  • Sandikci, Sembol Türkmen, Güvenen, Ayabakan, Gülcan, Koldas, Ozbek Kir, and Yenice, “Lipid Peroxidation and Antioxidant Defence System in Patients with Active or Inactive Behçet's Disease,” Acta Dermato-Venereologica, vol. 83, no. 5, pp. 342–346, 2003. View at Publisher · View at Google Scholar
  • Graham R Wallace, S John Curnow, Kaska Wloka, Mike Salmon, and Philip I Murray, “The role of chemokines and their receptors in ocular disease,” Progress in Retinal and Eye Research, vol. 23, no. 4, pp. 435–448, 2004. View at Publisher · View at Google Scholar
  • C Evereklioglu, Y Turkoz, M Calis, F Duygulu, and Ab Karabulut, “Tumour necrosis factor alpha, lipid peroxidation and NO center dot are increased and associated with decreased free-radical scavenging enzymes in patients with Weill-Marchesani syndrome,” Mediators Of Inflammation, vol. 13, no. 3, pp. 165–170, 2004. View at Publisher · View at Google Scholar
  • Alzírton de Lira Freire, Manoel B. Bertolo, Antônio Jose de Pinho Jr., Adil Muhib Samara, and Sandra Regina Muchinechi Fernandes, “Increased serum levels of interleukin-8 in polyarteritis nodosa and Behçet's disease,” Clinical Rheumatology, vol. 23, no. 3, pp. 203–205, 2004. View at Publisher · View at Google Scholar
  • I Kotter, I Gunaydin, M Zierhut, and N Stubiger, “The use of interferon alpha in Behcet disease: Review of the literature,” Seminars In Arthritis And Rheumatism, vol. 33, no. 5, pp. 320–335, 2004. View at Publisher · View at Google Scholar
  • Ina Kötter, Ilhan Günaydin, Manfred Zierhut, and Nicole Stübiger, “The use of interferon α in behçet disease: review of the literature,” Seminars in Arthritis and Rheumatism, vol. 33, no. 5, pp. 320–335, 2004. View at Publisher · View at Google Scholar
  • Ignatios Ikonomidis, John Lekakis, Kimon Stamatelopoulos, Nikolaos Markomihelakis, Phaedon G Kaklamanis, and Myron Mavrikakis, “Aortic elastic properties and left ventricular diastolic function in patients with Adamantiades-Behcet's disease,” Journal of the American College of Cardiology, vol. 43, no. 6, pp. 1075–1081, 2004. View at Publisher · View at Google Scholar
  • Yavuz Bardak, and Buket Cicioǧlu Aridoǧan, “The demonstration of serum interleukin 6-8, tumor necrosis factor-alpha, complement, and immunoglobulin levels in Behçet's disease with ocular involvement,” Ocular Immunology and Inflammation, vol. 12, no. 1, pp. 53–58, 2004. View at Publisher · View at Google Scholar
  • Cem Evereklioglu, “Managing the symptoms of Behçet’s disease,” Expert Opinion on Pharmacotherapy, vol. 5, no. 2, pp. 317–328, 2004. View at Publisher · View at Google Scholar
  • Cem Evereklioglu, “Managing the symptoms of Behçet's disease,” Expert Opinion on Pharmacotherapy, vol. 5, no. 2, pp. 317–328, 2004. View at Publisher · View at Google Scholar
  • Boyazit, Evereklioǧlu, Ozer, Kirtak, Bayazit, Kanlikama, and Inelöz, “Neurotological status in Behçet's disease and its ophthalmogical correlates,” Postgraduate Medical Journal, vol. 80, no. 950, pp. 724–728, 2004. View at Publisher · View at Google Scholar
  • Keystone, “The utility of tumour necrosis factor blockade in orphan diseases,” Annals of the Rheumatic Diseases, vol. 63, no. 2, pp. ii79–ii83, 2004. View at Publisher · View at Google Scholar
  • Andrew D. Dick, John V. Forrester, Janet Liversidge, and Andrew P. Cope, “The role of tumour necrosis factor (TNF-α) in experimental autoimmune uveoretinitis (EAU),” Progress in Retinal and Eye Research, vol. 23, no. 6, pp. 617–637, 2004. View at Publisher · View at Google Scholar
  • H Serhat Inaloz, C Evereklioglu, B Unal, N Kirtak, A Eralp, and Ss Inaloz, “The significance of immunohistochemistry in the skin pathergy reaction of patients with Behcet's syndrome,” Journal of the European Academy of Dermatology and Venereology, vol. 18, no. 1, pp. 56–61, 2004. View at Publisher · View at Google Scholar
  • M. Ben Ahmed, H. Houman, M. Miled, K. Dellagi, and H. Louzir, “Involvement of chemokines and Th1 cytokines in the pathogenesis of mucocutaneous lesions of Beh�et's disease,” Arthritis & Rheumatism, vol. 50, no. 7, pp. 2291–2295, 2004. View at Publisher · View at Google Scholar
  • Y Turkoz, C Evereklioglu, A Ozkiris, S Mistik, M Borlu, Ih Ozerol, F Duygulu, and O Ilhan, “Serum levels of soluble P-selectin are increased and associated with disease activity in patients with Behcet's syndrome,” Mediators Of Inflammation, no. 4, pp. 237–241, 2005. View at Publisher · View at Google Scholar
  • C Evereklioglu, “Current concepts in the etiology and treatment of Behcet disease,” Survey of Ophthalmology, vol. 50, no. 4, pp. 297–350, 2005. View at Publisher · View at Google Scholar
  • Cem Evereklioglu, “Current Concepts in the Etiology and Treatment of Behçet Disease,” Survey of Ophthalmology, vol. 50, no. 4, pp. 297–350, 2005. View at Publisher · View at Google Scholar
  • Masaru Takeuchi, Hideyuki Hokama, Rintaroh Tsukahara, Takeshi Kezuka, Hiroshi Goto, Jun-ichi Sakai, and Masahiko Usui, “Risk and prognostic factors of poor visual outcome in Behcet's disease with ocular involvement,” Graefe's Archive for Clinical and Experimental Ophthalmology, vol. 243, no. 11, pp. 1147–1152, 2005. View at Publisher · View at Google Scholar
  • Fuat Duygulu, Cem Evereklioglu, Mustafa Calis, Murat Borlu, Mustafa Çekmen, and Ozcan Ascioglu, “Synovial nitric oxide concentrations are increased and correlated with serum levels in patients with active Behçet’s disease: a pilot study,” Clinical Rheumatology, vol. 24, no. 4, pp. 324–330, 2005. View at Publisher · View at Google Scholar
  • Mustafa Calis, Filiz Ates, Cevat Yazici, Kader Kose, Mehmet Kirnap, Meltem Demir, Murat Borlu, and Cem Evereklioglu, “Adenosine deaminase enzyme levels, their relation with disease activity, and the effect of colchicine on adenosine deaminase levels in patients with Behçet’s disease,” Rheumatology International, vol. 25, no. 6, pp. 452–456, 2005. View at Publisher · View at Google Scholar
  • Hong Qiao, Koh-Hei Sonoda, Akiko Ariyama, Yuichiro Kuratomi, Yoh-Ichi Kawano, and Tatsuro Ishibashi, “CXCR2 expression on neutrophils is upregulated during the relapsing phase of ocular Behçet disease,” Current Eye Research, vol. 30, no. 3, pp. 195–203, 2005. View at Publisher · View at Google Scholar
  • S. Ercan. Tunc, Abdullah Dogan, Omer Gedikli, Cagatay Arslan, and Mehmet Sahin, “Assessment of aortic stiffness and ventricular diastolic functions in patients with Behçet’s disease,” Rheumatology International, vol. 25, no. 6, pp. 447–451, 2005. View at Publisher · View at Google Scholar
  • Y Ozkul, C Evereklioglu, M Borlu, S Taheri, M Calis, M Dundar, and O Ilhan, “5,10-Methylenetetrahydrofolate reductase C677T gene polymorphism in Behcet's patients with or without ocular involvement,” British Journal Of Ophthalmology, vol. 89, no. 12, pp. 1634–1637, 2005. View at Publisher · View at Google Scholar
  • Camilo Ribi, Sztajzel, Delavelle, and Chizzolini, “Efficacy of TNF α blockade in cyclophosphamide resistant neuro-Behçet disease,” Journal of Neurology, Neurosurgery and Psychiatry, vol. 76, no. 12, pp. 1733–1735, 2005. View at Publisher · View at Google Scholar
  • M. O. Oztas, M. Onder, M. A. Gurer, N. Bukan, and B. Sancak, “Serum interleukin 18 and tumour necrosis factor-alpha levels are increased in Behcet's disease,” Clinical and Experimental Dermatology, vol. 30, no. 1, pp. 61–63, 2005. View at Publisher · View at Google Scholar
  • Ahmed M. Abu El-Asrar, Emad B. Abboud, Hassan Aldibhi, and Abdulrahman Al-Arfaj, “Long-term safety and efficacy of infliximab therapy in refractory uveitis due to Behçet’s disease,” International Ophthalmology, vol. 26, no. 3, pp. 83–92, 2006. View at Publisher · View at Google Scholar
  • Andrea Marques-Deak, Giovanni Cizza, Farideh Eskandari, Sara Torvik, Israel C. Christie, Esther M. Sternberg, and Terry M. Phillips, “Measurement of cytokines in sweat patches and plasma in healthy women: Validation in a controlled study,” Journal of Immunological Methods, vol. 315, no. 1-2, pp. 99–109, 2006. View at Publisher · View at Google Scholar
  • Cem Evereklioglu, “Regarding neutrophil and lymphocyte responses to oral Streptococcus in Adamantiades-Behçet's disease,” FEMS Immunology and Medical Microbiology, vol. 47, no. 3, pp. 311–314, 2006. View at Publisher · View at Google Scholar
  • Gleb Slobodin, Yazeed Toukan, Itzhak Rosner, Michael Rozenbaum, Nina Boulman, Elsa Pavlotzky, Aharon Kessel, and Elias Toubi, “LPS-stimulated production of TNF-α by peripheral blood monocytes in patients with Behcet’s Disease,” Clinical Rheumatology, vol. 26, no. 5, pp. 764–767, 2006. View at Publisher · View at Google Scholar
  • Jonathan Samuels, and Robert Spiera, “Newer Therapeutic Approaches to the Vasculitides: Biologic Agents,” Rheumatic Disease Clinics of North America, vol. 32, no. 1, pp. 187–200, 2006. View at Publisher · View at Google Scholar
  • K. Hamzaoui, A. Hamzaoui, I. Ghorbel, M. Khanfir, and H. Houman, “Levels of IL-15 in Serum and Cerebrospinal Fluid of Patients with Beh�et's Disease,” Scandinavian Journal of Immunology, vol. 64, no. 6, pp. 655–660, 2006. View at Publisher · View at Google Scholar
  • Cem Evereklioglu, “Diagnostic dilemma between intestinal Behçet disease and inflammatory bowel disease with pyoderma gangrenosum,” World Journal of Gastroenterology, vol. 12, no. 35, pp. 5748, 2006. View at Publisher · View at Google Scholar
  • Keita Fujimori, Keiko Oh-i, Masaru Takeuchi, Naoyuki Yamakawa, Takaaki Hattori, Takeshi Kezuka, Hiroshi Keino, Jun Suzuki, Hiroshi Goto, Jun-ichi Sakai, and Masahiko Usui, “Circulating neutrophils in Behçet disease is resistant for apoptotic cell death in the remission phase of uveitis,” Graefe's Archive for Clinical and Experimental Ophthalmology, vol. 246, no. 2, pp. 285–290, 2007. View at Publisher · View at Google Scholar
  • Kramer, Monselise, Bahar, Cohen, Weinberger, and Goldenberg-Cohen, “Serum cytokine levels in active uveitis and remission,” Current Eye Research, vol. 32, no. 7-8, pp. 669–675, 2007. View at Publisher · View at Google Scholar
  • Cem Evereklioglu, “The migration pattern, patient selection with diagnostic methodological flaw and confusing naming dilemma in Behcet disease,” European Journal Of Echocardiography, vol. 8, no. 3, pp. 167–173, 2007. View at Publisher · View at Google Scholar
  • Jeong-Sik Byeon, Eun Kwang Choi, Nae Yun Heo, Seok Chan Hong, Seung-Jae Myung, Suk-Kyun Yang, Jin-Ho Kim, Jae-Kwan Song, Bin Yoo, and Chang Sik Yu, “Antitumor Necrosis Factor-α Therapy for Early Postoperative Recurrence of Gastrointestinal Behçetʼs Disease: Report of a Case,” Diseases of the Colon & Rectum, vol. 50, no. 5, pp. 672–676, 2007. View at Publisher · View at Google Scholar
  • C Evereklioglu, “The treatment schedule and historical naming process of Beh�et disease,” Journal of the European Academy of Dermatology and Venereology, vol. 21, no. 3, pp. 427–428, 2007. View at Publisher · View at Google Scholar
  • Pinar Öztas, Nese Lortlar, Muhterem Polat, Nuran Alli, Suna Ömeroglu, and Adil Basman, “Caspase-9 expression is increased in endothelial cells of active Behçet's disease patients,” International Journal of Dermatology, vol. 46, no. 2, pp. 172–176, 2007. View at Publisher · View at Google Scholar
  • O. Shaker, M.A. Ay El-Deen, H. El Hadidi, B.D. Grace, H. El Sherif, and A. Abdel Halim, “The role of heat shock protein 60, vascular endothelial growth factor and antiphospholipid antibodies in Beh�et disease,” British Journal of Dermatology, vol. 156, no. 1, pp. 32–37, 2007. View at Publisher · View at Google Scholar
  • C. Evereklioglu, “Regarding the naming dilemma of Beh�et disease in the 21st century,” Oral Diseases, vol. 13, no. 1, pp. 117–121, 2007. View at Publisher · View at Google Scholar
  • Seung-Ki Kwok, Sung-Hwan Park, Mi-Kyung Park, Mi-La Cho, Soo-Hong Seo, Ji-Hyeon Ju, Chong-Hyeon Yoon, and Ho-Youn Kim, “Upregulation of Macrophage Migration Inhibitory Factor (MIF) Production from Peripheral Blood Mononuclear Cells (PBMCs) Stimulated by Tumor Necrosis Factor (TNF)-α in Patients with Behcet's Syndrome,” The Journal of the Korean Rheumatism Association, vol. 14, no. 2, pp. 112, 2007. View at Publisher · View at Google Scholar
  • Won-Cheoul Jang, Yun-Hyoung Nam, Young-Chang Ahn, Sang-Hyun Lee, Sung-Hoon Park, Jung-Yoon Choe, Shin-Seok Lee, and Seong-Kyu Kim, “Interleukin-17F gene polymorphisms in Korean patients with Behçet’s disease,” Rheumatology International, vol. 29, no. 2, pp. 173–178, 2008. View at Publisher · View at Google Scholar
  • Evereklioglu, and Borlu, “Sustained remission after infliximab in a child with vasculitis refractory to conventional immunosuppressives including interferon-α,” British Journal of Ophthalmology, vol. 92, no. 8, pp. 1034–1149, 2008. View at Publisher · View at Google Scholar
  • Gülsen Akman-Demir, Erdem Tüzün, Sema Içöz, Nilüfer Yesilot, Sibel P. Yentür, Murat Kürtüncü, Melike Mutlu, and Güher Saruhan-Direskeneli, “Interleukin-6 in neuro-Behçet’s disease: Association with disease subsets and long-term outcome,” Cytokine, vol. 44, no. 3, pp. 373–376, 2008. View at Publisher · View at Google Scholar
  • J Shim, H O Byun, Y D Lee, E S Lee, and S Sohn, “Interleukin-6 small interfering RNA improved the herpes simplex virus-induced systemic inflammation in vivo Behcet’s disease-like mouse model,” Gene Therapy, vol. 16, no. 3, pp. 415–425, 2008. View at Publisher · View at Google Scholar
  • P.I. Murray, G.R. Wallace, S.J. Curnow, K. Pryce, N. Modi, B. Knight, E.M. Graham, J.E. Stewart, F. Fortune, and M.R. Stanford, “Serum cytokine profiles in Behçet's disease: Is there a role for IL-15 in pathogenesis?,” Immunology Letters, vol. 121, no. 1, pp. 7–12, 2008. View at Publisher · View at Google Scholar
  • Olfa Harzallah, Abdelhamid Kerkeni, Tarek Baati, and Silvia Mahjoub, “Oxidative stress: Correlation with Behçet's disease duration, activity and severity,” European Journal of Internal Medicine, vol. 19, no. 7, pp. 541–547, 2008. View at Publisher · View at Google Scholar
  • W. Lew, J.Y. Chang, J.Y. Jung, and D. Bang, “Increased expression of interleukin-23 p19 mRNA in erythema nodosum-like lesions of Behçet’s disease,” British Journal of Dermatology, vol. 158, no. 3, pp. 505–511, 2008. View at Publisher · View at Google Scholar
  • Selda Pelin Kartal Durmazlar, Ahmet Akgul, and Fatma Eskioglu, “Homocysteine May Involve in the Pathogenesis of Behcet's Disease by Inducing Inflammation,” Mediators of Inflammation, vol. 2008, pp. 1–9, 2008. View at Publisher · View at Google Scholar
  • Simon Lovestonepp. 845–905, 2009. View at Publisher · View at Google Scholar
  • Johannes Nowatzky, and Tova Chajek-Shaul, “Biomarkers in Behçet’s disease: diagnosis and disease activity,” International Journal of Clinical Rheumatology, vol. 4, no. 3, pp. 271–286, 2009. View at Publisher · View at Google Scholar
  • Andy Sun, Yi-Ping Wang, Jean-San Chia, Bu-Yuan Liu, and Chun-Pin Chiang, “Treatment with levamisole and colchicine can result in a significant reduction of IL-6, IL-8 or TNF-α level in patients with mucocutaneous type of Behcet’s disease,” Journal of Oral Pathology & Medicine, vol. 38, no. 5, pp. 401–405, 2009. View at Publisher · View at Google Scholar
  • Selda Pelin Kartal Durmazlar, Gul Bahar Ulkar, Fatma Eskioglu, Semih Tatlican, Ali Mert, and Ahmet Akgul, “Significance of serum interleukin-8 levels in patients with Behcet's disease: high levels may indicate vascular involvement,” International Journal of Dermatology, vol. 48, no. 3, pp. 259–264, 2009. View at Publisher · View at Google Scholar
  • Eriko Noda, Shigeki Yamanishi, Atsushi Shiraishi, and Yuichi Ohashi, “Cataract Surgery Under Infliximab Therapy in a Patient With Behçet’s Disease,” Journal of Ocular Pharmacology and Therapeutics, vol. 25, no. 5, pp. 467–470, 2009. View at Publisher · View at Google Scholar
  • Seong-Kyu Kim, Jung-Yoon Choe, Sung-Hoon Park, Sung Won Lee, Geon Ho Lee, and Won Tae Chung, “Increased Insulin Resistance and Serum Resistin in Korean Patients with Behçet's Disease,” Archives of Medical Research, vol. 41, no. 4, pp. 269–274, 2010. View at Publisher · View at Google Scholar
  • Robert B. Nussenblatt, and Scott M. Whitcuppp. 1–433, 2010. View at Publisher · View at Google Scholar
  • Davide Donghi, and Carlo Mainetti, “Infliximab for the treatment of refractory adamantiades-behçet disease with articular, intestinal, cerebral and ocular involvement,” Dermatology, vol. 220, no. 3, pp. 282–286, 2010. View at Publisher · View at Google Scholar
  • Agnès Hamzaoui, Hanene Chelbi, Fayçal Hai Sassi, and Kamel Hamzaoui, “Release of B cell-activating factor of the TNF family in bronchoalveolar lavage from Behçet's disease with pulmonary involvement,” Oxidative Medicine and Cellular Longevity, vol. 3, no. 2, pp. 122–128, 2010. View at Publisher · View at Google Scholar
  • Aliakbar Amirzargar, Farhad Shahram, Enayat Nikoopour, Nima Rezaei, Keyvan Saeedfar, Naghmeh Ziaei, and Fereydoun Davatchi, “Proinflammatory cytokine gene polymorphisms in Behcet's disease,” European Cytokine Network, vol. 21, no. 4, pp. 292–296, 2010. View at Publisher · View at Google Scholar
  • Huili Li, Masahiko Yoneda, Masayuki Takeyama, Iichiro Sugita, Hinako Tsunekawa, Hiroshi Yamada, Daisuke Watanabe, Tomoyuki Mukai, Masahiro Yamamura, Masayoshi Iwaki, and Masahiro Zako, “Effect of Infliximab on Tumor Necrosis Factor-Alpha-Induced Alterations in Retinal Microvascular Endothelial Cells and Retinal Pigment Epithelial Cells,” Journal of Ocular Pharmacology and Therapeutics, vol. 26, no. 6, pp. 549–556, 2010. View at Publisher · View at Google Scholar
  • Yasemin Ozdamar, Nilufer Berker, Gokhan Ertugrul, Ugur Gurlevik, Jale Karakaya, and Seyhan S Ozkan, “Is There a Change of Corneal Thickness in Uveitis with Behçet Disease?,” Cornea, vol. 29, no. 11, pp. 1265–1267, 2010. View at Publisher · View at Google Scholar
  • Remzi Karadaǧ, Cemile Koca, Yüksel Totan, Ramazan Yaǧci, Murat Aydin, Ayşe Serap Karadaǧ, Gülfer Akbay, Meral Ekşioǧlu, and Ramazan Yiǧitoǧlu, “Comparison of serum levels of IL-6, IL-8, TNF-α, C reactive protein and heat shock protein 70 in patients with active or inactive Behçet's disease,” Turkish Journal of Medical Sciences, vol. 40, no. 1, pp. 57–62, 2010. View at Publisher · View at Google Scholar
  • Jae Hee Hwang, Ju Kyoung Song, In Seol Yoo, Seung Taek Song, Jin Hyun Kim, Yun Jong Lee, Young Deok Bae, Hyo Jin Choi, Han Joo Baek, and Seong Wook Kang, “Associations between TBX21 Gene Polymorphisms and Korean Patients with Behçet's Disease,” The Journal of the Korean Rheumatism Association, vol. 17, no. 4, pp. 360, 2010. View at Publisher · View at Google Scholar
  • Işil Inanir, Ece Onur, Timur Pirildar, Kamer Gündüz, and Ahmet Var, “IL-2R, IL-6 and IL-8 levels in Behçet's disease,” Turkderm Deri Hastaliklari ve Frengi Arsivi, vol. 44, no. 4, pp. 213–215, 2010. View at Publisher · View at Google Scholar
  • Arzu Etem, Sembol Türkmen Yildirmak, Ebru Etem Önalan, Fehmi Baran, Hatice Seval, Macir Koldaş, Mustafa Çakmak, Mehmet Salih Gürel, and Necati Yenice, “Serum interleukin-6 and adiponectin levels in patients with active or inactive behçet's disease,” Turkiye Klinikleri Journal of Medical Sciences, vol. 30, no. 6, pp. 1837–1844, 2010. View at Publisher · View at Google Scholar
  • Robert B. Nussenblatt, “Behçet's Disease,” Uveitis, pp. 332–354, 2010. View at Publisher · View at Google Scholar
  • Nicole R. Benitah, Lucia Sobrin, and George N. Papaliodis, “The Use of Biologic Agents in the Treatment of Ocular Manifestations of Behcet’s Disease,” Seminars in Ophthalmology, vol. 26, no. 4-5, pp. 295–303, 2011. View at Publisher · View at Google Scholar
  • Aikaterini Arida, Kalliopi Fragiadaki, Eirini Giavri, and Petros P. Sfikakis, “Anti-TNF Agents for Behçet's Disease: Analysis of Published Data on 369 Patients,” Seminars in Arthritis and Rheumatism, vol. 41, no. 1, pp. 61–70, 2011. View at Publisher · View at Google Scholar
  • T. Karabag, M. Aydin, S. M. Dogan, R. Koca, C. Buyukuysal, M. R. Sayin, and N. Yavuz, “Investigation of the atrial electromechanical delay duration in Behcet patients by tissue Doppler echocardiography,” European Heart Journal - Cardiovascular Imaging, vol. 13, no. 3, pp. 251–256, 2011. View at Publisher · View at Google Scholar
  • Cem Evereklioglu, “Ocular Behçet disease,” Current Opinion in Ophthalmology, vol. 22, no. 6, pp. 508–516, 2011. View at Publisher · View at Google Scholar
  • E. Sahin, G. Karaman, M. Uslu, A. Karul, N. Sendur, and E. Savk, “Adiponectin levels, insulin resistance and their relationship with serum levels of inflammatory cytokines in patients with Behçet’s disease,” Journal of the European Academy of Dermatology and Venereology, pp. no–no, 2011. View at Publisher · View at Google Scholar
  • Reiko Horai, and Rachel R. Caspi, “Cytokines in Autoimmune Uveitis,” Journal of Interferon & Cytokine Research, vol. 31, no. 10, pp. 733–744, 2011. View at Publisher · View at Google Scholar
  • Yoon Suk Jung, Seung Won Kim, Jin Young Yoon, Jin Ha Lee, Soung Min Jeon, Sung Pil Hong, Tae Il Kim, Won Ho Kim, and Jae Hee Cheon, “Expression of a soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) correlates with clinical disease activity in intestinal Behcetʼs disease,” Inflammatory Bowel Diseases, vol. 17, no. 10, pp. 2130–2137, 2011. View at Publisher · View at Google Scholar
  • Asier Eguia-Del Valle, Rafael Martinez-Conde-Llamosas, Jose López-Vicente, Agurne Uribarri-Etxebarria, and José-Manuel Aguirre-Urizar, “Salivary levels of Tumour Necrosis Factor-alpha in patients with recurrent aphthous stomatitis,” Medicina Oral, Patologia Oral y Cirugia Bucal, vol. 16, no. 1, pp. e33–e36, 2011. View at Publisher · View at Google Scholar
  • Eun Chun Han, Sung Bin Cho, Keun Jae Ahn, Sang Ho Oh, Jihyun Kim, Dong Soo Kim, Kwang Hoon Lee, and Dongsik Bang, “Expression of Pro-inflammatory Protein S100A12 (EN-RAGE) in Behçet's Disease and Its Association with Disease Activity: A Pilot Study,” Annals of Dermatology, vol. 23, no. 3, pp. 313, 2011. View at Publisher · View at Google Scholar
  • Suguru Kadowaki, Nozomu Matsuda, Arata Moriya, Masahiro Ebitani, Akioh Yoshihara, Kouichirou Nakamura, Hitoshi Mochizuki, and Yoshikazu Ugawa, “Infliximab treatment trial in a patient with neuro-Behcet's disease unresponsive to other treatments,” Rinsho Shinkeigaku, vol. 51, no. 4, pp. 261–266, 2011. View at Publisher · View at Google Scholar
  • Djamel Messaoudene, Houda Belguendouz, Mohamed Ahmedi, Tarek Benabdekader, Fifi Otmani, Malika Terahi, Pierre Youinou, and Chafia Touil-boukoffa, “Ex vivo effects of flavonoïds extracted from Artemisia herba alba on cytokines and nitric oxide production in Algerian patients with Adamantiades-Behçet's disease,” Journal of Inflammation, vol. 8, no. 1, pp. 35, 2011. View at Publisher · View at Google Scholar
  • Pratibha Dubey, Anura P. Jayasooriya, and Sukhinder K. Cheema, “Fish oil induced hyperlipidemia and oxidative stress in BioF1B hamsters is attenuated by elderberry extract,” Applied Physiology, Nutrition, and Metabolism, vol. 37, no. 3, pp. 472–479, 2012. View at Publisher · View at Google Scholar
  • D. Perra, M. A. Alba, J. L. Callejas, M. Mesquida, R. Rios-Fernandez, A. Adan, N. Ortego, R. Cervera, and G. Espinosa, “Adalimumab for the treatment of Behcet's disease: experience in 19 patients,” Rheumatology, vol. 51, no. 10, pp. 1825–1831, 2012. View at Publisher · View at Google Scholar
  • Esin Aktas Cetin, Fulya Cosan, Umut Can Kucuksezer, Sema Bilgic, Yonca Cagatay, Ahmet Gul, and Gunnur Deniz, “Behçet’s disease: immunological relevance with arthritis of ankylosing spondylitis,” Rheumatology International, vol. 33, no. 3, pp. 733–741, 2012. View at Publisher · View at Google Scholar
  • Yasunobu Kato, and Toshiyuki Yamamoto, “Serum levels of GRO-α are elevated in association with disease activity in patients with Behçet’s disease,” International Journal of Dermatology, vol. 51, no. 3, pp. 286–289, 2012. View at Publisher · View at Google Scholar
  • Meltem A. Melikoglu, Cahit Kacar, Aysegul Cort, Gultekin Yucel, and Mutay Aslan, “Oxidases and oxygenases in regulation of neutrophil redox pathways in Behçet’s disease patients,” Journal of Enzyme Inhibition and Medicinal Chemistry, vol. 27, no. 1, pp. 12–17, 2012. View at Publisher · View at Google Scholar
  • S. Cho, J. Kim, S. B. Cho, Z. Zheng, M.J. Choi, D.Y. Kim, and D. Bang, “Immunopathogenic characterization of cutaneous inflammation in Behçet’s disease,” Journal of the European Academy of Dermatology and Venereology, 2012. View at Publisher · View at Google Scholar
  • Filiz Namdar Pekiner, Emre Aytugar, Gulderen Yanikkaya Demirel, and Mehmet Oguz Borahan, “Interleukin-2, interleukin-6 and T regulatory cells in peripheral blood of patients with Behçet's disease and recurrent aphthous ulcerations,” Journal of Oral Pathology and Medicine, vol. 41, no. 1, pp. 73–79, 2012. View at Publisher · View at Google Scholar
  • Ali Bicer, “Musculoskeletal Findings in Behcet's Disease,” Pathology Research International, vol. 2012, pp. 1–5, 2012. View at Publisher · View at Google Scholar
  • Hisashi Kanemaru, Takamitsu Makino, Masatoshi Jinnin, Aya Yonemitsu, Katsunari Makino, and Hironobu Ihn, “Case of neuro-Behçet's disease successfully maintained a remission using infliximab for 2 years,” The Journal of Dermatology, 2013. View at Publisher · View at Google Scholar
  • Sultan Al Rashidi, Abdullah Al Fawaz, Dustan Kangave, and Ahmed M. Abu El-Asrar, “Long-term Clinical Outcomes in Patients with Refractory Uveitis Associated with Behçet Disease Treated with Infliximab,” Ocular Immunology and Inflammation, pp. 1–7, 2013. View at Publisher · View at Google Scholar
  • M.D. Redondo-Pachón, R. Enríquez, A.E. Sirvent, E. Andrada, R. Noguera-Pons, I. Millán, and F. Amorós, “Tocilizumab Treatment for Nephrotic Syndrome Due to Amyloidosis in Behcet’s Disease,” Renal Failure, vol. 35, no. 4, pp. 547–550, 2013. View at Publisher · View at Google Scholar
  • Hiroshi Yamada, Masahiko Yoneda, Shingo Inaguma, Daisuke Watanabe, Shogo Banno, Kazuhiro Yoshikawa, Keigo Mizutani, Masayoshi Iwaki, and Masahiro Zako, “Infliximab counteracts tumor necrosis factor-α-enhanced induction of matrix metalloproteinases that degrade claudin and occludin in non-pigmented ciliary epithelium,” Biochemical Pharmacology, 2013. View at Publisher · View at Google Scholar
  • Jung-Yoon Choe, Hwajeong Lee, Sang Gyung Kim, Min Ji Kim, Sung-Hoon Park, and Seong-Kyu Kim, “The distinct expressions of interleukin-15 and interleukin-15 receptor α in Behçet’s disease,” Rheumatology International, 2013. View at Publisher · View at Google Scholar
  • Luca Cantarini, Antonio Vitale, Perla Scalini, Charles A. Dinarello, Donato Rigante, Rossella Franceschini, Gabriele Simonini, Giulia Borsari, Francesco Caso, Orso Maria Lucherini, Bruno Frediani, Ilaria Bertoldi, Leonardo Punzi, Mauro Galeazzi, and Rolando Cimaz, “Anakinra treatment in drug-resistant Behcet’s disease: a case series,” Clinical Rheumatology, 2013. View at Publisher · View at Google Scholar
  • Shengping Hou, Jian Qi, Dan Liao, Qi Zhang, Jing Fang, Yan Zhou, Yunjia Liu, Lin Bai, Meifen Zhang, Aize Kijlstra, and Peizeng Yang, “Copy Number Variations of Complement Component C4 Are Associated With Behçet's Disease but Not With Ankylosing Spondylitis Associated With Acute Anterior Uveitis,” Arthritis & Rheumatism, vol. 65, no. 11, pp. 2963–2970, 2013. View at Publisher · View at Google Scholar
  • Monica Castrichini, Pietro Enea Lazzerini, Alessandra Gamberucci, Pier Leopoldo Capecchi, Rossella Franceschini, Mariarita Natale, Mohamed Hammoud, Antonio Moramarco, Stefania Zimbone, Elena Gianchecchi, Cinzia Montilli, Gianluca Ricci, Enrico Selvi, Luca Cantarini, Mauro Galeazzi, and Franco Laghi-Pasini, “The purinergic P2×7 receptor is expressed on monocytes in Behçet's disease and is modulated by TNF-α,” European Journal of Immunology, 2013. View at Publisher · View at Google Scholar
  • Rashmi Kulkarni, Ajit Deshpande, Ravi Saxena, and Kiran Saxena, “A study of serum malondialdehyde and cytokine in tuberculosis patients,” Journal of Clinical and Diagnostic Research, vol. 7, no. 10, pp. 2140–2142, 2013. View at Publisher · View at Google Scholar
  • Liang Liang, Xiaoyu Tan, Qingyun Zhou, Yi Zhu, Yuan Tian, Hongsong Yu, Aize Kijlstra, and Peizeng Yang, “IL-1 beta Triggered by Peptidoglycan and Lipopolysaccharide through TLR2/4 and ROS-NLRP3 Inflammasome-Dependent Pathways Is Involved in Ocular Behcet's Disease,” Investigative Ophthalmology & Visual Science, vol. 54, no. 1, pp. 402–414, 2013. View at Publisher · View at Google Scholar
  • Satoshi Tanida, Nagamu Inoue, Kiyonori Kobayashi, Makoto Naganuma, Fumihito Hirai, Bunei Iizuka, Kenji Watanabe, Keiichi Mitsuyama, Takuya Inoue, Yoshiaki Ishigatsubo, Yasuo Suzuki, Masakazu Nagahori, Satoshi Motoya, Shiro Nakamura, Vipin Arora, Anne M. Robinson, Roopal B. Thakkar, and Toshifumi Hibi, “Adalimumab for the Treatment of Japanese Patients With Intestinal Behçet’s Disease,” Clinical Gastroenterology and Hepatology, 2014. View at Publisher · View at Google Scholar
  • Buket Cicioglu Aridogan, Mehmet Yildirim, Vahide Baysal, H. Serhat Inaloz, Kiymet Baz, and Selcuk Kaya, “Serum Levels of IL-4, IL-10, IL-12, IL-13 and IFN-Gamma in Behçet's Disease,” The Journal of Dermatology, vol. 30, no. 8, pp. 602–607, 2014. View at Publisher · View at Google Scholar
  • Abullah Alfawaz, Sultan Alrashidi, Hatem Kalantan, Hani Al-Mezaine, and Ahmed M. Abu El-Asrar, “Cataract surgery under systemic infliximab therapy in patients with refractory uveitis associated with Behcet disease,” Annals Of Saudi Medicine, vol. 34, no. 4, pp. 328–333, 2014. View at Publisher · View at Google Scholar
  • Cemile Tugba Altunel, Semih Tatlican, Bilgen Oktay, Zeliha Ulukaradag, and Ozlem Gulbahar, “Serum visfatin levels in Behcet's disease patients and their correlation with disease activity,” Turkderm-Archives of The Turkish Dermatology and Venerology, vol. 48, no. 2, pp. 82–86, 2014. View at Publisher · View at Google Scholar
  • Xiaomei Wang, and Zhongshan Zhang, “The antitumor activity of a red alga polysaccharide complexes carrying 5-Fluorouracil,” International Journal of Biological Macromolecules, 2014. View at Publisher · View at Google Scholar
  • Noha Seoudi, Lesley A. Bergmeier, Eleni Hagi-Pavli, David Bibby, and Michael A. Curtis, “The role of TLR2 and 4 in Behcet's disease pathogenesis,” Innate Immunity, vol. 20, no. 4, pp. 412–422, 2014. View at Publisher · View at Google Scholar
  • Roba M. Talaat, Mohamed E. Ashour, Iman H. Bassyouni, and Ahmed A. Raouf, “Polymorphisms of interleukin 6 and interleukin 10 in Egyptian people with Behcet's disease,” Immunobiology, 2014. View at Publisher · View at Google Scholar
  • Manal El Menyawi, Mary Fawzy, Zeinab Al-Nahas, Amr Edris, Hanan Hussein, Olfat Shaker, and Hussein Elwan, “Serum tumor necrosis factor alpha (TNF-α) level in patients with Behçet’s disease: Relation to clinical manifestations and disease activity,” The Egyptian Rheumatologist, 2014. View at Publisher · View at Google Scholar
  • Manfred Zierhut, Ahmet M. Abu El-Asrar, Bahram Bodaghi, and Ilknur Tugal-Tutkun, “Therapy of Ocular Behçet Disease,” Ocular Immunology and Inflammation, vol. 22, no. 1, pp. 64–76, 2014. View at Publisher · View at Google Scholar
  • Gianluigi Mazzoccoli, Angela Matarangolo, Rosa Rubino, Michele Inglese, and Angelo De Cata, “Behçet syndrome: from pathogenesis to novel therapies,” Clinical and Experimental Medicine, 2014. View at Publisher · View at Google Scholar
  • Madhavi Latha Alasandagutti, Meenakshi Ponnana, Ramya Sivangala, Shruthi Thada, Lavanya Joshi, Hidayath Hussain, Soheb Sadath Ansari, Vijayalakshmi Valluri, and Suman Latha Gaddam, “Role of IFN-γ and IL-6 Cytokines and Their Association in Determining Susceptibility to Chronic Idiopathic Urticaria,” Genetic Testing and Molecular Biomarkers, pp. 141119133502007, 2014. View at Publisher · View at Google Scholar
  • Pinar Ozuguz, Ayse Anil Karabulut, Murat Tulmac, Ucler Kisa, Mukadder Kocak, and Ozgur Gunduz, “Markers of Endothelial Dysfunction and Evaluation of Vascular Reactivity Tests in Behcet Disease,” International Journal of Offender Therapy and Comparative Criminology, vol. 65, no. 10, pp. 937–943, 2014. View at Publisher · View at Google Scholar
  • Wan Chen, Haotian Lin, Xiaojian Zhong, Zhaochuan Liu, Yu Geng, Chufang Xie, and Weirong Chen, “Discrepant Expression of Cytokines in Inflammation- and Age-Related Cataract Patients,” Plos One, vol. 9, no. 10, 2014. View at Publisher · View at Google Scholar
  • Z. Takci, A. S. Karadag, D. T. Ertugrul, and S. G. Bilgili, “Elevated insulin resistance in patients with recurrent aphthous stomatitis,” Clinical Oral Investigations, 2014. View at Publisher · View at Google Scholar
  • Ming-Ming Yang, Timothy Y. Y. Lai, Fiona O. J. Luk, and Chi-Pui Pang, “The Roles Of Genetic Factors In Uveitis And Their Clinical Significance,” Retina, vol. 34, no. 1, pp. 1–11, 2014. View at Publisher · View at Google Scholar
  • Olfat G. Shaker, Shereen O. Tawfic, Amira M. El-Tawdy, Mohamed H. M. El-Komy, Manal El Menyawi, and Ahmed A. Heikal, “ Expression of TNF- α , April and BCMA in Behcet’s Disease ,” Journal of Immunology Research, vol. 2014, pp. 1–6, 2014. View at Publisher · View at Google Scholar
  • Pierre-André Jarrot, and Gilles Kaplanski, “Anti-TNF-Alpha Therapy and Systemic Vasculitis,” Mediators of Inflammation, vol. 2014, pp. 1–9, 2014. View at Publisher · View at Google Scholar
  • Feyzahan Ekici, Emine Esra Karaca, Şafak Korkmaz, Osman Yüksel, Özlem Gülbahar, Murat Alper, Sevim Ercan, and Meral Or, “Effect of the Toll-Like Receptor 4 Antagonist Eritoran on Retinochoroidal Inflammatory Damage in a Rat Model of Endotoxin-Induced Inflammation,” Mediators of Inflammation, vol. 2014, pp. 1–9, 2014. View at Publisher · View at Google Scholar
  • Ju Young Choi, Bunsoon Choi, Ju A. Shim, Eun-So Lee, Do Young Kim, Dongsik Bang, and Seonghyang Sohn, “IL-2/IL-2 antibody immune complex regulates HSV-induced inflammation through induction of IL-2 receptor alpha, beta, and gamma in a mouse model,” Immunobiology, 2015. View at Publisher · View at Google Scholar
  • N. Eikelis, D. Hering, P. Marusic, C. Sari, A. Walton, S. Phillips, E. Lambert, J. Duval, H. Krum, G. Lambert, M. Esler, and M. Schlaich, “The Effect of Renal Denervation on Endothelial Function and Inflammatory Markers in Patients with Resistant Hypertension,” International Journal of Cardiology, 2015. View at Publisher · View at Google Scholar
  • Stavros Stavrakis, Mary Beth Humphrey, Benjamin J. Scherlag, Yanqing Hu, Warren M. Jackman, Hiroshi Nakagawa, Deborah Lockwood, Ralph Lazzara, and Sunny S. Po, “Low-Level Transcutaneous Electrical Vagus Nerve Stimulation Suppresses Atrial Fibrillation,” Journal of the American College of Cardiology, vol. 65, no. 9, pp. 867–875, 2015. View at Publisher · View at Google Scholar
  • Adebimpe Wasiu Olalekan, Faremi Ayodeji Oluwaseun, Hassan Abdul-Wasiu Oladele, and Adeyemi Damilare Akeem, “Evaluation of electrolyte imbalance among tuberculosis patients receiving treatments in Southwestern Nigeria,” Alexandria Journal of Medicine, 2015. View at Publisher · View at Google Scholar
  • Wasiu Olalekan Adebimpe, Ayodeji Oluwaseun Faremi, and Sulaiman Adebayo Nassar, “Effects of treatment on free radicals in patients with pulmonary tuberculosis in South Western Nigeria,” African Health Sciences, vol. 15, no. 4, pp. 1256–1261, 2015. View at Publisher · View at Google Scholar
  • Serpil Taheri, Murat Borlu, Cem Evereklioglu, Sevda Yesim Ozdemir, and Yusuf Ozkul, “mRNA Expression Level of Interleukin Genes in the Determining Phases of Behçet's Disease,” Annals of Dermatology, vol. 27, no. 3, pp. 291, 2015. View at Publisher · View at Google Scholar
  • Noha Seoudi, Lesley A. Bergmeier, Eleni Hagi-Pavli, David Bibby, and Farida Fortune, “The seroprevalence and salivary shedding of herpesviruses in Behcet's syndrome and recurrent aphthous stomatitis,” Journal Of Oral Microbiology, vol. 7, 2015. View at Publisher · View at Google Scholar
  • Sharni Lee Hardcastle, Ekua Weba Brenu, Samantha Johnston, Thao Nguyen, Teilah Huth, Sandra Ramos, Donald Staines, and Sonya Marshall-Gradisnik, “Serum Immune Proteins in Moderate and Severe Chronic Fatigue Syndrome/Myalgic Encephalomyelitis Patients,” International Journal Of Medical Sciences, vol. 12, no. 10, pp. 764–772, 2015. View at Publisher · View at Google Scholar
  • Manuela Marsili, Valentina Marzetti, Marta Lucantoni, Giuseppe Lapergola, Marco Gattorno, Francesco Chiarelli, and Luciana Breda, “Autoimmune sensorineural hearing loss as presenting manifestation of paediatric Behçet disease responding to adalimumab: a case report,” Italian Journal of Pediatrics, vol. 42, no. 1, 2016. View at Publisher · View at Google Scholar
  • Rashmi Anant Kulkarni, and Ajit Ramesh Deshpande, “Anti-inflammatory and antioxidant effect of ginger in tuberculosis,” Journal of Complementary and Integrative Medicine, vol. 13, no. 2, pp. 201–206, 2016. View at Publisher · View at Google Scholar
  • Kiichiro Kanamitsu, Akira Shimada, Ritsuo Nishiuchi, Tomonari Shigemura, Yozo Nakazawa, Kenichi Koike, Yuichi Kodama, Yuichi Shinkoda, Yoshifumi Kawano, Kozo Yasui, Koji Sasaki, Ryosuke Kajiwara, Hirokazu Tsukahara, and Atsushi Manabe, “Pediatric intestinal Behçet disease complicated by myeloid malignancies,” International Journal of Hematology, 2016. View at Publisher · View at Google Scholar
  • Mi-Young Son, Young-Dae Kim, Binna Seol, Mi-Ok Lee, Hee-Jun Na, Bin Yoo, Jae-Suk Chang, and Yee Sook Cho, “Biomarker Discovery by Modeling Behçet's Disease with Patient-Specific Human Induced Pluripotent Stem Cells,” Stem Cells and Development, 2016. View at Publisher · View at Google Scholar
  • Tim B. van der Houwen, P. Martin van Hagen, Wilhemina M.C. Timmermans, Sophinus J.W. Bartol, King H. Lam, Jasper H. Kappen, Menno C. van Zelm, and Jan A. M. van Laar, “Chronic signs of memory B cell activation in patients with Behçet’s disease are partially restored by anti-tumour necrosis factor treatment,” Rheumatology, pp. kew366, 2016. View at Publisher · View at Google Scholar
  • Sevgi Irtegun, Gulsum Pektanc, Zeynep M. Akkurt, Mehtap Bozkurt, Fatih M. Turkcu, and Sevgi Kalkanli-Tas, “ Pharmacological Inactivation of Src Family Kinases Inhibits LPS-Induced TNF- α Production in PBMC of Patients with Behçet’s Disease ,” Mediators of Inflammation, vol. 2016, pp. 1–7, 2016. View at Publisher · View at Google Scholar
  • Sila Seremet, and Mehmet Salih Gurel, “Miscellaneous skin disease and the metabolic syndrome,” Clinics in Dermatology, 2017. View at Publisher · View at Google Scholar
  • Bunsoon Choi, Hasan M. Sayeed, S.M. Shamsul Islam, and Seonghyang Sohn, “Role of N-acetyl galactosamine-4-SO 4 , a ligand of CD206 in HSV-induced mouse model of Behçet's disease,” European Journal of Pharmacology, 2017. View at Publisher · View at Google Scholar
  • Jurgen Sota, Donato Rigante, Giuseppe Lopalco, Bruno Frediani, Rossella Franceschini, Mauro Galeazzi, Florenzo Iannone, Gian Marco Tosi, Claudia Fabiani, and Luca Cantarini, “Biological therapies for the treatment of Behçet’s disease-related uveitis beyond TNF-alpha blockade: a narrative review,” Rheumatology International, 2017. View at Publisher · View at Google Scholar
  • Thomas W. McNally, Erika M. Damato, Philip I. Murray, Alastair K. Denniston, and Robert J. Barry, “An update on the use of biologic therapies in the management of uveitis in Behçet’s disease: a comprehensive review,” Orphanet Journal of Rare Diseases, vol. 12, no. 1, 2017. View at Publisher · View at Google Scholar
  • Alireza Sadeghi, Fereydoun Davatchi, Farhad Shahram, Arezoo Karimimoghadam, Majid Alikhani, Aiyoub Pezeshgi, Saeideh Mazloomzadeh, Bahar Sadeghi-Abdollahi, and Masoud Asadi-Khiavi, “Serum Profiles of Cytokines in Behcet’s Disease,” Journal of Clinical Medicine, vol. 6, no. 5, pp. 49, 2017. View at Publisher · View at Google Scholar
  • Fahd Adeeb, Maria Usman Khan, Austin G. Stack, and Alexander D. Fraser, “Etiology, Immunopathogenesis and Biomarkers in Behçet’s disease,” Behcet's Disease, 2017. View at Publisher · View at Google Scholar
  • Esra Sahli, and Ozlem Gurbuz-Koz, “Ocular Manifestations of Behçet’s Disease,” Behcet's Disease, 2017. View at Publisher · View at Google Scholar
  • Angela Mauro, Donato Rigante, and Rolando Cimaz, “Investigational drugs for treatment of juvenile idiopathic arthritis,” Expert Opinion on Investigational Drugs, pp. 1–7, 2017. View at Publisher · View at Google Scholar
  • B. Kroegler, G. Di Muzio, F. Giovannangeli, M. De Mattia, C. Perricone, and R. Perricone, “Behçet's Disease and Etanercept: Eighty Weeks of Experience,” European Journal of Inflammation, vol. 7, no. 2, pp. 117–120, 2017. View at Publisher · View at Google Scholar
  • Beata Zelazowska-Rutkowska, Bogdan Cylwik, and Malgorzata Mrugacz, “Comparison of the diagnostic power of serum IL-6, IL-8 and TNF-α for the idiopathic anterior uveitis in children,” Clinical Laboratory, vol. 63, no. 11-12, pp. 1889–1895, 2017. View at Publisher · View at Google Scholar
  • Shahriar Alipour, Ebrahim Sakhinia, Alireza Khabbazi, Nasser Samadi, Zohreh Babaloo, Mahdi Azad, Somayeh Abolhasani, Jafar Farhadi, Golamreza Jadideslam, Neda Roshanravan, and Mohammad Nouri, “Methylation Status of Interleukin-6 Gene Promoter in Patients with Behçet's Disease,” Reumatología Clínica, 2018. View at Publisher · View at Google Scholar
  • Eda Balkan, Sadullah Keles, Asli Kara, Necmettin Akdeniz, Handan Bilen, Nilnur Eyerci, and Hasan Dogan, “Cytokine, C-reactive protein, and heat shock protein mRNA expression levels in patients with active behçet’s uveitis,” Medical Science Monitor, vol. 24, pp. 1511–1516, 2018. View at Publisher · View at Google Scholar
  • Yasemin Ozdamar, Nilufer Berker, Gul Bahar, Emel Soykan, Tolga Bicer, Seyhan Sonar Ozkan, and Jale Karakaya, “Inflammatory mediators and posterior segment involvement in ocular Behçet disease,” European Journal of Ophthalmology, vol. 19, no. 6, pp. 998–1003, 2018. View at Publisher · View at Google Scholar